CIK 0001837607 · <br>Emerging growth company
AEON Biopharma, Inc.
Sign in to watch- Ticker
- AEON
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853940478
- Phone
- (949) 354-6499
- Business address
- 130 VANTIS DRIVE, SUITE 170, ALISO VIEJO, CA, 92656
- Former names
- Priveterra Acquisition Corp.
- 3 Insider Initial Statement of Ownership
- 8-K Event Regulation FD disclosure
- CERT Other Certification
- 25 Other Notification of Removal from Listing
- 8-A12B Other Registration of Securities
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
- S-4MEF Other S-4MEF
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Delisting notice · Regulation FD disclosure
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Delisting notice · Regulation FD disclosure
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Executive or director change · Shareholder vote results · Other events
- 425 Deal Prospectus/Communication re Business Combination
- DEFA14A Proxy Proxy Materials
- 8-K Event Regulation FD disclosure · Other events
- DEFA14A Proxy Proxy Materials
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Unregistered share sale · Other events
Page 13 of 19 · 363 filings